Matthew R. Patterson

Co-Founder at Audentes Therapeutics, Inc.

Matthew R. Patterson

Matthew R. Patterson

Co-Founder at Audentes Therapeutics, Inc.

Overview
Career Highlights

Amicus Therapeutics, Inc.
Audentes Therapeutics, Inc.

RelSci Relationships

761

Number of Boards

5

Birthday

1972

Age

47

Relationships
RelSci Relationships are individuals Matthew R. Patterson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Compass Therapeutics LLC

Relationship likelihood: Strong

Managing Partner at 5AM Venture Management LLC

Relationship likelihood: Strong

Co-Founder at Rapidscan Pharma Solutions, Inc.

Relationship likelihood: Strong

Executive Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

General Partner & Co-Head of Global Private Equity at OrbiMed Advisors LLC

Relationship likelihood: Strong

Director & Treasurer at The Biotechnology Institute

Relationship likelihood: Strong

General Manager, Cell Therapy at GE Healthcare, Inc.

Relationship likelihood: Strong

Treasurer & Director at Alliance for Regenerative Medicine

Relationship likelihood: Strong

Director at Alliance for Regenerative Medicine

Relationship likelihood: Strong

President, Chief Executive Officer & Director at E-Scape Bio, Inc. (California)

Relationship likelihood: Strong

Paths to Matthew R. Patterson
Potential Connections via
Relationship Science
You
Matthew R. Patterson
Co-Founder at Audentes Therapeutics, Inc.
Education
B.A., Biochemistry
Class of 1993

Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME.

Career History
Co-Founder
2012 - Current

Audentes Therapeutics, Inc. is a biotechnology company, which engages on development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. Its products include AT001 for the treatment of X-Linked Myotubular Myopathy, AT002 for the treatment of Pompe disease, and AT003 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA.

Entrepreneur-in-Residence
2011 - Prior

OrbiMed focuses exclusively on global investments across the entire spectrum of private and publicly-traded life sciences companies. They seek to invest in the most promising investment opportunities regardless of a company's stage of development. The firm invests at all stages of development from private start-ups and university spinouts to the largest global pharmaceutical companies. OrbiMed focuses on companies involved in drug development, drug discovery and medical devices, with particular emphasis on mid-stage private companies. Investments typically range from $5 million to $40 million. OrbiMed is generally a lead investor and takes an active role on their portfolio companies' boards of directors

President & Chief Executive Officer
2004 - 2011

Amicus Therapeutics, Inc. engages in the discovery, development, and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.

Boards & Committees
Member, Board of Directors
2010 - Current

Gilda’s Club New York City was named for Gilda Radner, the brilliant comedian and one of the original cast members of Saturday Night Live. Gilda’s Club now have over 5,000 members, including many at our community satellites in Brooklyn and the Bronx, and our Manhattan Clubhouse has seen over 100,000 member visits.

Member, Board of Directors
2015 - Prior

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine.The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare.Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 +
2011

Gilda’s Club New York City was named for Gilda Radner, the brilliant comedian and one of the original cast members of Saturday Night Live. Gilda’s Club now have over 5,000 members, including many at our community satellites in Brooklyn and the Bronx, and our Manhattan Clubhouse has seen over 100,000 member visits.

Transactions
Details Hidden

Audentes Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Audentes Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Audentes Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Audentes Therapeutics, Inc. is a biotechnology company, which engages on development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. Its products include AT001 for the treatment of X-Linked Myotubular Myopathy, AT002 for the treatment of Pompe disease, and AT003 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matthew R. Patterson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matthew R. Patterson's profile does not indicate a business or promotional relationship of any kind between RelSci and Matthew R. Patterson.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/matthew-r-patterson-3502088
  • https://relationshipscience.com/person/matthew-r-patterson-3502088